Impact of Tax on Dendritic Cell Immunologic Function
Project Number1F31NS044801-01A1
Contact PI/Project LeaderMOSTOLLER, KATE M
Awardee OrganizationPENNSYLVANIA STATE UNIV HERSHEY MED CTR
Description
Abstract Text
DESCRIPTION (provided by applicant): Human T cell leukemia virus type I (HTLV-I) is the etiologic agent of both adult T cell leukemia (ATL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAMKSP). Although the genesis of HAM/TSP likely involves several steps, the generation of a highly specific and effective population of Tax-specific CD8+ cytotoxic T lymphocytes (CTLs) that migrate to the central nervous system (CNS) is of central importance in the genesis of neurologic disease. Presentation of antigenic Tax peptides by mature dendritic cells (DCs) to CD8+ T cells likely plays an important role in the induction of a Tax-specific CTL response. The central hypothesis of the proposed studies is that Tax induces functional alterations in DCs causing their maturation and activation, thus increasing the efficiency of CDS+ T cell activation and leading to the generation of a highly reactive Tax-specific CTL compartment that participates in the genesis of HAM/TSP. The specific aims of the study are to examine the (1) effect of Tax on the activation of murine dendritic cells and primary human peripheral blood-derived dendritic cells; (2) effect of Tax on the immunologic function of murine dendritic cells and primary human peripheral blood-derived dendritic cells; and (3) the pathway and mechanism by which Tax induces dendritic cell maturation.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Escherichia coliclinical researchcytotoxic T lymphocytedendritic cellsenzyme linked immunosorbent assayflow cytometrygel mobility shift assayhuman T cell lymphotropic virus type 1human tissueleukocyte activation /transformationpredoctoral investigatorprotein structure functionspastic paralysistissue /cell culturevirus protein
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
129348186
UEI
TNKGNDAWB445
Project Start Date
01-August-2003
Project End Date
30-April-2004
Budget Start Date
01-August-2003
Budget End Date
30-April-2004
Project Funding Information for 2003
Total Funding
$21,704
Direct Costs
$21,704
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Neurological Disorders and Stroke
$21,704
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F31NS044801-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F31NS044801-01A1
Patents
No Patents information available for 1F31NS044801-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F31NS044801-01A1
Clinical Studies
No Clinical Studies information available for 1F31NS044801-01A1
News and More
Related News Releases
No news release information available for 1F31NS044801-01A1
History
No Historical information available for 1F31NS044801-01A1
Similar Projects
No Similar Projects information available for 1F31NS044801-01A1